Resonance Health Limited
ASX: RHT.AX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Andrew Duncan Harrison
- Employees
- 18
- Headquarters
- Burswood, Australia
- IPO year
- 2000
- Market cap
- A$23.4M
- Website
- https://www.resonancehealth.com
Loading RHT…
Loading profile data…Frequently asked questions about RHT
What does Resonance Health Limited (RHT.AX) do?
Resonance Health Limited, a healthcare technology and services company, designs, develops, and manufactures software-as-medical devices in the Asia Pacific, North America, South America, Europe, the Middle East, and Africa. It offers FerriScan, a non-invasive MRI based system for quantifying liver iron concentration (LIC); FerriSmart, an artific...
Where does RHT.AX trade?
Resonance Health Limited (RHT.AX) trades on the Australian Securities Exchange.
What sector is RHT.AX in?
Resonance Health Limited (RHT.AX) operates in the Healthcare sector, specifically in the Medical - Healthcare Information Services industry.
Who is the CEO of Resonance Health Limited?
Andrew Duncan Harrison is the chief executive officer of Resonance Health Limited (RHT.AX).
Where is Resonance Health Limited headquartered?
Resonance Health Limited is headquartered in Australia.
Does RHT.AX pay a dividend?
Resonance Health Limited (RHT.AX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RHT.AX go public?
Resonance Health Limited (RHT.AX) completed its initial public offering in 2000.